Ventive Hospital

Should I buy, sell or hold Ventive Hospitality Ltd?

Why is Ventive Hospitality Ltd falling/rising?

As of 04-Aug, Ventive Hospitality Ltd's stock price is rising to 626.20, reflecting a 0.6% increase after two days of decline, with significant investor interest shown by a 176.79% rise in delivery volume. Despite a year-to-date decline of 17.67%, the company has strong fundamentals, including a 126.90% growth in net sales and an 84.24% increase in net profit over the last four quarters.

As of 04-Aug, Ventive Hospitality Ltd's stock price is rising, currently at 626.20, reflecting an increase of 3.75 (0.6%). This upward movement follows a trend reversal after two consecutive days of decline. The stock has outperformed its sector by 1.13% today, indicating positive momentum. <BR><BR>Additionally, there has been a significant rise in investor participation, with delivery volume increasing by 176.79% compared to the 5-day average, suggesting heightened interest in the stock. Despite the stock's year-to-date decline of 17.67% and a one-year drop of 18.54%, the company has demonstrated strong financial performance, with net sales growing at an annual rate of 126.90% and operating profit increasing by 80.31%. <BR><BR>The company has also reported positive results for the last four consecutive quarters, with a notable increase in net profit of 84.24% and a PAT of Rs 233.49 crore, which has grown at 186.4% compared to the previous four-quarter average. These strong fundamentals, combined with a fair valuation indicated by a PEG ratio of 0.1, contribute to the stock's current rise.

Which are the latest news on Ventive Hospital?

When is the next results date for Ventive Hospitality Ltd?

The next results date for Ventive Hospitality Ltd is August 4, 2026.

The next results date for Ventive Hospitality Ltd is scheduled for August 4, 2026.

What does Ventive Hospital do?

Ventive Hospitality Ltd operates in the Hotels & Resorts industry as a Small Cap company, reporting net sales of 779 Cr and a net profit of 230 Cr for the quarter ending March 2026. The company has a market cap of INR 14,666 Cr and a P/E ratio of 34.00.

Overview: <BR>Ventive Hospitality Ltd operates in the Hotels & Resorts industry and is classified as a Small Cap company.<BR><BR>History: <BR>The company was incorporated in 2002 and underwent a status change from Private Limited to Public Limited on August 28, 2024. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 779 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 230 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 14,666 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 34.00 <BR>Industry P/E: 35 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.38 <BR>Return on Equity: 7.84% <BR>Price to Book: 2.67 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

How big is Ventive Hospital?

As of 10th June, Ventive Hospitality Ltd has a market capitalization of 14,666.00 Cr, with recent net sales of 2,461.07 Cr and a net profit of 425.65 Cr. Shareholder's funds are 4,806.55 Cr, and total assets amount to 9,841.36 Cr.

As of 10th June, Ventive Hospitality Ltd has a market capitalization of 14,666.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Ventive Hospitality Ltd reported Net Sales of 2,461.07 Cr and a Net Profit of 425.65 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 4,806.55 Cr and Total Assets of 9,841.36 Cr.

Who are the peers of the Ventive Hospital?

Ventive Hospital's peers include Indian Hotels Co, ITC Hotels, EIH, Chalet Hotels, Leela Palaces Ho, Lemon Tree Hotel, I T D C, Mahindra Holiday, Juniper Hotels, and Samhi Hotels. In terms of management risk, growth, and capital structure, Indian Hotels Co and EIH perform the best, while Mahindra Holiday has the lowest 1-year return at -36.56%, compared to Ventive Hospital's -16.96%.

Peers: The peers of Ventive Hospital are Indian Hotels Co, ITC Hotels, EIH, Chalet Hotels, Leela Palaces Ho, Lemon Tree Hotel, I T D C, Mahindra Holiday, Juniper Hotels, and Samhi Hotels.<BR><BR>Quality Snapshot: Excellent management risk is observed at Indian Hotels Co and EIH, while Average management risk is found at ITC Hotels, Lemon Tree Hotel, I T D C, Mahindra Holiday, and Juniper Hotels, and the rest have Below Average management risk. For growth, Excellent growth is noted at Indian Hotels Co, EIH, Chalet Hotels, Lemon Tree Hotel, and the rest have Below Average or Average growth, with Average growth specifically at Leela Palaces Ho and I T D C. In terms of Capital Structure, Excellent capital structure is seen at Indian Hotels Co, EIH, and I T D C, while Average capital structure is at Ventive Hospital, and Below Average capital structure is observed at Chalet Hotels, Leela Palaces Ho, Lemon Tree Hotel, Mahindra Holiday, Juniper Hotels, and Samhi Hotels.<BR><BR>Return Snapshot: The peer with the highest 1-year return is I T D C at -7.14%, while the peer with the lowest is Mahindra Holiday at -36.56%. Ventive Hospital's 1-year return of -16.96% is better than Mahindra Holiday's but worse than I T D C's. Additionally, several peers, including Lemon Tree Hotel, Mahindra Holiday, Juniper Hotels, and Samhi Hotels, have negative six-month returns.

Are Ventive Hospitality Ltd latest results good or bad?

Ventive Hospitality Ltd's latest Q4 FY26 results show strong operational performance with a 96.84% QoQ net profit increase and record net sales; however, high valuations and declining return metrics raise concerns, leading to a cautious "SELL" rating from analysts.

Ventive Hospitality Ltd's latest results for Q4 FY26 can be characterized as strong in terms of operational performance, but there are underlying concerns that temper the overall outlook.<BR><BR>The company reported a consolidated net profit of ₹229.54 crores, which represents a remarkable increase of 96.84% quarter-on-quarter (QoQ). Additionally, net sales reached an all-time quarterly high of ₹778.79 crores, reflecting a 13.61% QoQ growth. The operating margin also improved significantly to 49.47%, up 410 basis points from the previous quarter, indicating enhanced operational efficiency.<BR><BR>Despite these impressive figures, the stock's reaction post-results was muted, highlighting a disconnect between operational performance and market expectations. Analysts have expressed concerns regarding the company's high valuations, with a price-to-earnings ratio of 36.26x and a price-to-book value of 3.14x, which are considered expensive given the company's return on equity (ROE) of just 4.67%. Furthermore, the return on capital employed (ROCE) has declined to 8.98%, well below historical averages, raising questions about the sustainability of the recent profit growth.<BR><BR>In summary, while Ventive Hospitality's latest results show significant operational improvements, the high valuations and weak return metrics suggest caution for investors. The overall sentiment leans towards a "SELL" rating due to these concerns, despite the positive quarterly performance.

How has been the historical performance of Ventive Hospital?

Ventive Hospital experienced significant financial growth from March 2024 to March 2025, with net sales increasing to 1,604.71 Cr from 477.98 Cr, and operating profit rising to 828.65 Cr. However, profit after tax slightly decreased to 181.03 Cr, and earnings per share dropped to 5.15 due to changes in equity capital.

Answer:<BR>The historical performance of Ventive Hospital shows significant growth in various financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Ventive Hospital reported net sales of 1,604.71 Cr, a substantial increase from 477.98 Cr in the previous year. Total operating income mirrored this growth, reaching 1,604.71 Cr compared to 477.98 Cr in March 2024. The total expenditure, excluding depreciation, rose to 843.88 Cr from 194.15 Cr, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) also saw a notable rise to 828.65 Cr from 300.56 Cr, despite an increase in interest expenses to 256.69 Cr from 47.22 Cr. Profit before tax increased to 309.65 Cr from 205.19 Cr, while profit after tax slightly decreased to 181.03 Cr from 166.32 Cr, leading to a consolidated net profit of 120.29 Cr compared to 166.32 Cr in the prior year. The earnings per share (EPS) dropped significantly to 5.15 from 159.31, reflecting changes in equity capital, which rose to 23.35 Cr from 10.44 Cr. On the balance sheet, total liabilities stood at 9,841.36 Cr, with total assets also matching this figure, indicating a balanced position. The cash flow from operating activities was 677.00 Cr, while cash flow from investing activities showed an outflow of 1,661.00 Cr, and financing activities contributed an inflow of 1,363.00 Cr, resulting in a net cash inflow of 379.00 Cr, increasing the closing cash and cash equivalents to 412.00 Cr.

Is Ventive Hospital overvalued or undervalued?

As of February 14, 2025, Ventive Hospital is considered very expensive and overvalued with a PE ratio of 141.20, significantly higher than its peers, and has underperformed the Sensex with a recent stock return of -1.53%.

As of 14 February 2025, Ventive Hospital's valuation grade has moved from does not qualify to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued, with a PE ratio of 141.20, an EV to EBITDA of 25.91, and a Price to Book Value of 3.64, all of which are substantially higher than industry norms. <BR><BR>In comparison to its peers, Ventive Hospital's PE ratio is notably higher than Indian Hotels Co. Ltd., which stands at 66.81, and ITC Hotels, at 65.26, both of which are also categorized as very expensive. The company's return performance has lagged behind the Sensex recently, with a 1-week stock return of -1.53% compared to a 1.36% gain in the Sensex, reinforcing the view that Ventive Hospital is currently overvalued in the market.

What is the technical trend for Ventive Hospital?

As of March 10, 2025, Ventive Hospital's trend is mildly bullish, supported by positive On-Balance Volume and a recent monthly gain, despite a slight weekly decline and current price below the previous close.

As of 10 March 2025, the technical trend for Ventive Hospital has changed to mildly bullish. The weekly Dow Theory indicates a mildly bullish stance, while the On-Balance Volume (OBV) is bullish on a weekly basis. Despite a recent decline of 2.11% over the past week, the stock has shown a positive return of 1.25% over the last month, suggesting some resilience. The current price is 747.00, which is below the previous close of 748.90, but today's high of 762.25 indicates potential upward movement. Overall, the indicators suggest a mildly bullish sentiment, though caution is warranted given the recent price action.

Who are the top shareholders of the Ventive Hospital?

The top shareholder of Ventive Hospital is Premsagar Infra Realty Private Limited, holding 37.28% of shares. Other significant shareholders include mutual funds with 5.2%, foreign institutional investors at 2.92%, and individual investors at 2.08%.

The top shareholders of Ventive Hospital include a mix of promoters, mutual funds, and foreign institutional investors. The majority shareholder is Premsagar Infra Realty Private Limited, which holds 37.28% of the shares. Additionally, the promoters collectively have a pledged holding of 7.6993%. <BR><BR>In terms of institutional investors, mutual funds hold 5.2% of the shares through 8 different schemes, while 23 foreign institutional investors (FIIs) collectively own 2.92%. The highest public shareholder is Quant Mutual Fund-Quant ELSS Tax Saver Fund, which has a holding of 4.97%. Individual investors account for 2.08% of the total shareholding.

Has Ventive Hospital declared dividend?

No Dividend History Available